A negative correlation between lncRNA PVT‐1 and miR‐34a and the role of both of these factors in the regulation of inflammatory pathways34, 82, 83, 84 evoke the idea that PVT‐1 can control the progression of inflammation in COVID‐19 patients via targeting miR‐34a. The gene discussed is PVT1; the disease is COVID-19.